French pharma major Sanofi (Euronext: SAN) has started early global shipments of its monoclonal antibody Beyfortus ...

The Russian pharmaceutical market, valued at around $41 billion, continues to be a magnet for Indian pharmaceutical companies ...

The European Council of Minister last week said it is ready to begin negotiations with the European Parliament, having agreed ...

Knight will have the exclusive rights to distribute, promote, market and sell the products in Canada, and said it will begin ...

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) and French pharma major Sanofi (Euronext: SAN) on Saturday presented ...

US biotech PureTech Health (Nasdaq: PRTC) is positioning its lead candidate LYT-100 as a potential disruptor in the treatment of idiopathic pulmonary fibrosis (IPF), a rare lung condition long ...